Feasibility and safety of intravenous tolvaptan administration immediately upon ICU admission after cardiac surgery with cardiopulmonary bypass.

Narita M, Shirakura K, Hikasa E, Fukuta H, Tamaru Y, Nakatsu T, Kadohama T, Akasaka N, Kamiya H

Open source

DOI
10.1007/s00595-026-03470-2
Published
2026 Sep 10
Container
Surgery today
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00595-026-03470-2,
  title = {Feasibility and safety of intravenous tolvaptan administration immediately upon ICU admission after cardiac surgery with cardiopulmonary bypass.},
  author = {Narita M and Shirakura K and Hikasa E and Fukuta H and Tamaru Y and Nakatsu T and Kadohama T and Akasaka N and Kamiya H},
  year = {2026},
  journal = {Surgery today},
  doi = {10.1007/s00595-026-03470-2},
  url = {https://doi.org/10.1007/s00595-026-03470-2}
}

RIS

TY  - JOUR
TI  - Feasibility and safety of intravenous tolvaptan administration immediately upon ICU admission after cardiac surgery with cardiopulmonary bypass.
AU  - Narita M
AU  - Shirakura K
AU  - Hikasa E
AU  - Fukuta H
AU  - Tamaru Y
AU  - Nakatsu T
AU  - Kadohama T
AU  - Akasaka N
AU  - Kamiya H
PY  - 2026
JO  - Surgery today
DO  - 10.1007/s00595-026-03470-2
UR  - https://doi.org/10.1007/s00595-026-03470-2
ER  - 

APA

M, N., K, S., E, H., H, F., Y, T., T, N., T, K., N, A., & H, K. (2026). Feasibility and safety of intravenous tolvaptan administration immediately upon ICU admission after cardiac surgery with cardiopulmonary bypass.. Surgery today. https://doi.org/10.1007/s00595-026-03470-2

Source records